DEEPSEQAI LLC

Biotech · Private

AI model for identifying highly developable single-domain antibodies from molecular sequences and structures

Grants
$275K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Development of an AI-Driven Humanized and Developable Single-Domain Library Design Platform for Accelerated Drug Discovery$274,797
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2336Decibel Therapeutics—$63M
23373P BIOTECHNOLOGIES, INC.——
2338Mythic Therapeutics—$53M
2339DEEPSEQAI LLC——
2340Tallac Therapeutics, Inc.—$21M
2341AION Healthspan, Inc.—$2.9M
2342Avm Biotechnology, LLC—$5.8M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.